PA9159 inhalation aerosol

PA9159 · Anhui Palo Alto Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PA9159 inhalation aerosol, covering 2025-12-30 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma [Phase 2]